Bristol-Myers Squibb Rights
CELG.RT
16 hedge funds and large institutions have $157K invested in Bristol-Myers Squibb Rights in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0.03% → 0.02% (-0%)
7% less capital invested
Capital invested by funds: $169K → $157K (-$12.4K)
11% less funds holding
Funds holding: 18 → 16 (-2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.98K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$202 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FCM
1
FourWorld Capital Management
New York
| $69K | – | – | – |
|
|
MS
2
Maven Securities
St Helier,
Jersey
| $46.8K | – | – | – |
|
|
TCA
3
Transcend Capital Advisors
Madison,
New Jersey
| $13.9K | – | – | – |
|
|
DC
4
Davenport & Co
Richmond,
Virginia
| $11K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $5.92K | -$1.98K | -14,714 | -23% |
|
|
6
Citadel Advisors
Miami,
Florida
| $4.38K | -$19 | -142 | -0.4% |
|
7
Fifth Third Bancorp
Cincinnati,
Ohio
| $2.36K | – | – | – |
|
|
PAG
8
Private Advisor Group
Morristown,
New Jersey
| $1.77K | – | – | – |
|
|
TPA
9
Trivium Point Advisory
Westport,
Connecticut
| $1.18K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $197 | -$1 | -5 | -0.3% |
|
11
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $29 | – | – | – |
|
12
Morgan Stanley
New York
| $19 | – | – | – |
|
|
OC
13
Oakworth Capital
Birmingham,
Alabama
| $15 | – | – | – |
|
14
Wells Fargo
San Francisco,
California
| $3 | – | – | – |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$4K | -26,786 | Closed |
|
|
16
Osaic Holdings
Scottsdale,
Arizona
| – | -$202 | -1,501 | -99% |
|
CELG.RT Hedge Fund Activity: Q4 2022 in Review
16 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q4 2022, worth a combined $157K — down 7.3% from $169K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CELG.RT and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $4K sold.
- 16 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q4 2022, down from 18 in Q3 2022.
- Funds reported $157K of Bristol-Myers Squibb Rights stock for Q4 2022, down 7.3% quarter-over-quarter.
- 0 funds opened new Bristol-Myers Squibb Rights positions in Q4 2022 and 2 closed out, a net change of -2 holders.
- The largest Bristol-Myers Squibb Rights seller in Q4 2022 was UBS Group, an estimated $4K sold.
Based on aggregated 13F filings for Q4 2022.